Korea News
-
Korea's diabetes drug Envlo to enter $1.54 B market in Brazil and Mexico
Korea | News | 0 Comment | 01 Mar, 2023
South Korean firm Daewoong Pharmaceutical has announced the launching of their national new drug #36, 'Envlo (ingredient...Read more
-
Korean firm Rayence unveils first X-ray detector with next-gen technology
Korea | News | 0 Comment | 24 Feb, 2023
South Korea-based company Rayence has successfully applied the 'SPAD-GS' technology to 3D detectors. The technology...Read more
-
Japan's Olympus buys Korean gastrointestinal stent firm Taewoong Medical for $370 M
Korea | News | 0 Comment | 24 Feb, 2023
Olympus Corporation, a global medtech company headquartered in Japan, has agreed to acquire Taewoong Medical Co.,&n...Read more
-
Korea proposes use of light to treat wounds, instead of topical ointments
Korea | News | 0 Comment | 23 Feb, 2023
A team of scientists at the Pohang University of Science and Technology (POSTECH) in South Korea has developed an i...Read more
-
Korea's GC Biopharma receives WHO prequalification for chickenpox vaccine
Korea | News | 0 Comment | 22 Feb, 2023
GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has announced that the World Health Organ...Read more
-
Uniting microbiome industry leaders in APAC with 'Microbiome Connect: Asia'
Korea | News | 0 Comment | 21 Feb, 2023
With Asia Pacific (APAC) set to experience transformative growth, the need to build meaningful connections with microbio...Read more
-
Korean firms to develop novel microbiome treatment for Parkinson's disease
Korea | News | 1 Comment | 21 Feb, 2023
South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...Read more
-
Anthill and SparkLabs to boost international growth for Indian and Korean startups
Korea | News | 0 Comment | 17 Feb, 2023
Anthill Ventures, an India-headquartered startup accelerator fund and growth ecosystem, and SparkLabs, a renowned global...Read more
-
Korea's LegoChemBio buys first-in-class antibody from Swiss startup for cancer therapy
Korea | News | 0 Comment | 15 Feb, 2023
South Korea's LegoChem Biosciences Inc. has announced a license agreement with Elthera AG, a biotechnology sta...Read more
-
Korea's HanAll Biopharma invests in American biotech startup Interon
Korea | News | 0 Comment | 14 Feb, 2023
South Korea based HanAll Biopharma is investing in Interon Laboratories, Inc., a US-based biotechnology company focusing...Read more
-
Korea designs smart contact lens for diagnosing and treating glaucoma
Korea | News | 0 Comment | 13 Feb, 2023
A research team at Pohang University of Science and Technology (POSTECH) in South Korea has developed a smart conta...Read more
-
SK bioscience invests $261 M to establish vaccine-biopharma hub in Korea
Korea | News | 0 Comment | 09 Feb, 2023
SK bioscience, a South Korea-based innovative vaccine and biotech company committed to promoting human health from preve...Read more
-
Korea's Wellmarker Bio inks cancer drug trial collaboration with Merck
Korea | News | 0 Comment | 10 Feb, 2023
South Korean firm Wellmarker Bio (WMBIO) has entered a clinical trial collaboration and supply agreement with Merck (kno...Read more
-
Dutch biotech firm Synaffix announces first partnership with Korean company
Korea | News | 0 Comment | 08 Feb, 2023
Synaffix B.V., a Dutch biotechnology company focused on commercialising its clinical-stage platform technology for the d...Read more
-
Korea's Qurient inks agreement with TB Alliance for new anti-tuberculosis agent
Korea | News | 2 Comment | 06 Feb, 2023
Qurient, a clinical-stage biotechnology company based in South Korea, and TB Alliance, a not-for-profit organisation ded...Read more
-
Korea | News | 1 Comment | 01 Feb, 2023
South Korea-based startup Lunit, in partnership with leading precision oncology company Guardant Health in the US, has a...Read more
-
Korea | News | 0 Comment | 30 Jan, 2023
Biotech startup SN BioScience and pharma major Boryeong have signed a domestic manufacturing technology transfer an...Read more
-
Korea's Samsung Biologics to continue expansion in capacity, geography and portfolio in 2023
Korea | News | 1 Comment | 27 Jan, 2023
At the 2023 J.P. Morgan Healthcare Conference in January, Samsung Biologics, a fully integrated CDMO offering state...Read more
